131-18-0 | Sigma-Aldrich

Data Sheet - P8950

under study and the sensitivity of the instrument used. References 1. Shipp, M., J. Immunol., 131(5), 2458 (1983). 2. Shakelford, D., Immunol. Rev., 66, 133 (1982). 3. Spies, T., Proc. Nat. Acad. Sci

Data Sheet - F1902 - Lot 066H8815

under study and the sensitivity of the instrument used. References 1. Shipp, M., J. Immunol., 131(5), 2458 (1983). 2. Shackelford, D., Immunol. Rev., 66, 133 (1982). 4. Accolla, R., S. Sem. Hematol

Product Information Sheet - SE120084

clomiphene citrate and human menopausal gonadotropin, J. In Vitro Fertil. Embryo Transfer, 1985; 2: 123-131. 16. Ratcliffe, W.A., Carter, G.D., Dowsett, M., et al., Oestradiol assays: applications and guidelines

Product Information Sheet - L5266

., et al., The purification, composition and specificity of wheat-germ agglutinin. Biochem. J., 131, 155-162 (1973). 7. LeVine, D., et al., The purification and characterization of wheat-germ agglutinin

Product Information Sheet - L4895

., et al., The purification, composition and specificity of wheat-germ agglutinin. Biochem. J., 131, 155-162 (1973). 7. LeVine, D., et al., The purification and characterization of wheat-germ agglutinin

Verfication summary-03-0202-00

108% 3 1:16 8.14 0.6 7% 130.23 0.6 0% 113% SMC® Human NF-L High Sensitivity Immunoassay Kit (03-0202-00) Verification Summary 03-0202-00 Rev. 18-OCT-2022 12 of 13

Verfication summary-03-0202-00

108% 3 1:16 8.14 0.6 7% 130.23 0.6 0% 113% SMC® Human NF-L High Sensitivity Immunoassay Kit (03-0202-00) Verification Summary 03-0202-00 Rev. 18-OCT-2022 12 of 13

Product Information Sheet - L7017

., et al., The purification, composition and specificity of wheat-germ agglutinin. Biochem. J., 131, 155-162 (1973). 7. LeVine, D., et al., The purification and characterization of wheat-germ agglutinin

MILLIPLEX MAP Phospho Akt1/PKBa (Thr308) MAPmates, Assay Buffer 1

Thr308) Beads (20X), Assay Buffer 1 42-645 38 131 µL 1 tube MILLIPLEX MAP Anti-phospho Akt1/PKBα (Thr308), biotin (20X), Assay Buffer 1 44-645 n/a 131 µL 1 tube MILLIPLEX MAP MCF-7 Cell Lysate:

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

Serotransferrin precursor 393 8 131 3 551 11 193 6 571 11 543 11 67 1 194 5 828 14 1051 19 IPI00022432 Transthyretin precursor 47 1 138 3 74 1 59 1 59 1 86 2 66 1

Infectious Disease Antibodies

FITC Conjugated IF FITC Ms IgG2ak 500 ug MAB858-3F- 5 Respiratory Syncytial Virus (RSV), clone 131-2G, Biotinylated IF Biotin Ms IgG1k 100 ug MAB858-2B Respiratory syncytial virus (RSV), clone

An integrated platform for real-time dynamic culturing and analysis of hypoxia

D P 1 0 S ig n al I n te n si ty 800 600 400 200 0 No rm ox ic 40 m in 80 m

Quantitative multiplex analysis of 48 analytes using the MILLIPLEX®Human Cytokine/Chemokine/Growth Factor Panel

Systemic Lupus Erythematosus. Scandinavian Journal of Immunology Volume 79, Issue 2 February 2014, pages 131-136. https://doi.org/10.1111/ sji.12135. 5. Mitsuyama, K., et al. (2006). Increased Circulating

Protocol: Mouse Lipocalin-2/NGAL

10 165 5 82 88 107% 2.5 41 46 112% 1.25 21 27 131% 6 10 74 5

An Update on Ligands for Prostanoid Receptors

220 (1994). 13. Toh, H., et al., FEBS Lett., 361, 17-21 (1995). 14. Hatae, N. et al., J. Biochem., 131, 781-784 (2002). 15. Nishizawa, E.E., et al., Prostaglandins, 9, 109-121 (1975). 16. Toda, N., Prostaglandins

Dispensette Organic Bottle-Top Dispenser Leaflet

0.2 - 2 0.05 0.5 10 0.1 2 4700 120 4700 121 0.5 - 5 0.1 0.5 25 0.1 5 4700 130 4700 131 1 -

Dispensette III Bottle-Top Dispenser Leaflet

0.2 - 2 0.05 0.5 10 0.1 2 4700 120 4700 121 0.5 - 5 0.1 0.5 25 0.1 5 4700 130 4700 131 1 -

WideScreen Rat Kidney Toxicity Assays

Rat, other species not tested Sample Size 1 µl Sample Types Urine, plasma* Intra-assay CV 0%-18% Inter-assay CV 3%-16% Cross-reactivity Negligible (<1%) *dilutions vary; see User Protocol

Protocol: Rat/Mouse Fibroblast Growth Factor-21 (FGF-21)

E1, F1 20 µL 0 µL 20 µL of Tube 4 G1, H1 20 µL 0 µL 20 µL of Tube 3 A2, B2 20 µL 0 µL

Product Information Sheet - Z339857

2.5 2 18 Z34,013-8 0.75 48 2.35 1 17 Z34,014-6 1 10 11

Eshmuno®Q resin - For superior anion exchange chromatography

Starting material 15.0 8.7 131 (100%) 1.356 20.3 (100%) 0.150 2.2 (100%) Flow-through+wash 25.3 4.1 104 (79%) 0.015 0.4 (2%) 0.004 0.1 (5%) Elute (1 M NaCl) 23.6 1.0 23 (18%) 0.749 17.6 (87%) 0.098

Detergents Properties and Applications

.1 0.2-0.9 0.2 0.06 0.027 0.012 Aggregation Number 10 8-16 20-40 70 * * 66 63 * 98 * * * 84 * * 60 131 2232 * * * * * * * * 100-155 * * * 60 HLB *

Product Information Sheet - Z339563

2.5 2 18 Z34,013-8 0.75 48 2.35 1 17 Z34,014-6 1 10 11

Product Information Sheet - Z339571

2.5 2 18 Z34,013-8 0.75 48 2.35 1 17 Z34,014-6 1 10 11

Protocol: Rat/Mouse C-Peptide 2 ELISA Kit

f 1 0 X H R P W a s h B u ff e r w it h 9 0 0 m L d e -i o n iz e d w a te r.

BRAND Katalog EN

15 259 295 01 - 295 19 132 Cat. No. Page 297 01 - 297 38 131 300 02 - 300 18 132 305 02 - 305 18 131 309 00 260 311 06 - 311 15 138 314 02 - 314 15 132 317

Advantages of Mannitol in Pharmaceutical Granulation Processes

moisture-induced polymorphic transition. International Journal of Pharmaceutics, 2003. 258(1-2): 121-131. 3 Amidon, GL, et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation

Protocol- EZRMFGF21-26K

20 µL 0 µL 20 µL of QC 1 A3, B3 20 µL 0 µL 20 µL of QC 2 C3, D3 0 µL 30 µL 10

Human STEMCCA Cre-Excisable Constitutive Polycistronic (OKSM) Lentivirus Reprogramming Kit

2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factor. Cell 131: 861-872. 5. Yu J, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells

Human STEMCCA Constitutive Polycistronic (OKSM) Lentivirus Reprogramming Kit

2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factor. Cell 131: 861-872. 5. Yu J, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells